Cargando…

The clinical utility of comprehensive measurement of autoimmune disease-related antibodies in patients with advanced solid tumors receiving immune checkpoint inhibitors: a retrospective study

BACKGROUND: The comprehensive measurement of autoimmune disease-related antibodies (Abs) before immune checkpoint inhibitor (ICI) treatment may be useful for predicting the development of immune-related adverse events (irAEs); however, the clinical utility is not well known. MATERIALS AND METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Izawa, N., Shiokawa, H., Onuki, R., Hamaji, K., Morikawa, K., Saji, H., Ohashi, H., Kasugai, S., Hayakawa, N., Ohara, T., Sunakawa, Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058890/ https://www.ncbi.nlm.nih.gov/pubmed/35247869 http://dx.doi.org/10.1016/j.esmoop.2022.100415

Ejemplares similares

Comprehensive immune profiling of patients with advanced urothelial or renal cell carcinoma receiving immune checkpoint blockade
por: Lavoie, Jean-Michel, et al.
Publicado: (2022)

Learning Needs of Patients with Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint Inhibitors
por: Lopez-Olivo, Maria A., et al.
Publicado: (2023)

Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors
por: Gilbert, Danielle, et al.
Publicado: (2023)

Hyperprogressive Disease (HPD) in Solid Tumours Receiving Immune Checkpoint Inhibitors in a Real-World Setting
por: Kanjanapan, Yada, et al.
Publicado: (2023)

Influence of menopause on mandibular bone quantity and quality in Japanese women receiving dental implants
por: Munakata, M., et al.
Publicado: (2011)

Checkpoint Inhibitors in Melanoma Patients with Underlying Autoimmune Disease
por: Dietz, Hilary, et al.
Publicado: (2021)

Geographic heterogeneity in the outcomes of patients receiving immune checkpoint inhibitors for advanced solid tumors: a meta-analysis
por: Li, Manyu, et al.
Publicado: (2021)

Immune Checkpoints as Therapeutic Targets in Autoimmunity
por: Paluch, Christopher, et al.
Publicado: (2018)

Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer
por: Karayama, M., et al.
Publicado: (2020)

nab-Paclitaxel as a potential partner with checkpoint inhibitors in solid tumors
por: Soliman, Hatem H
Publicado: (2016)

Live‐attenuated vaccines in a cryopyrin‐associated periodic syndrome patient receiving canakinumab treatment during infancy
por: Watanabe, Misa, et al.
Publicado: (2017)

Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells
por: Ager, Ann, et al.
Publicado: (2016)

Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now?
por: Yokode, Masataka, et al.
Publicado: (2021)

Utility of Shear Wave Elastography for Diagnosing Chronic Autoimmune Thyroiditis
por: Fukuhara, Takahiro, et al.
Publicado: (2015)

Use of immune checkpoint inhibitors in patients with solid tumors and pre-existing autoimmune or inflammatory disease: real-world data
por: Calvo, Virginia, et al.
Publicado: (2021)

A purine metabolic checkpoint that prevents autoimmunity and autoinflammation
por: Saveljeva, Svetlana, et al.
Publicado: (2022)

Corneal Transplant Rejections in Patients Receiving Immune Checkpoint Inhibitors
por: Moshirfar, Majid, et al.
Publicado: (2022)

Immune Checkpoints in Solid Organ Transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2023)

Inflammatory markers in autoimmunity induced by checkpoint inhibitors
por: Husain, Beate, et al.
Publicado: (2021)

Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes
por: Gámez-Díaz, Laura, et al.
Publicado: (2021)

Dermatological Autoimmune Considerations of Immune Checkpoint Therapy
por: Fane, Lauren S., et al.
Publicado: (2022)

Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside
por: Wu, Linda, et al.
Publicado: (2021)

Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation
por: Shukla, Nikhil A, et al.
Publicado: (2020)

Immune-related Adverse Events in Patients With Cancer Receiving Influenza Vaccination and Immune Checkpoint Inhibitors
por: Groeneveld, Geert H, et al.
Publicado: (2020)

Clinical utility of geriatric assessment tools in older patients with gastrointestinal cancer
por: Doi, Ayako, et al.
Publicado: (2023)

Autoimmune Neurology: The Need for Comprehensive Care
por: Abbatemarco, Justin R., et al.
Publicado: (2021)

Prediction model for hyperprogressive disease in patients with advanced solid tumors received immune-checkpoint inhibitors: a pan-cancer study
por: Long, Yaping, et al.
Publicado: (2023)

Phase I study of aflibercept in combination with docetaxel in Japanese patients with advanced solid malignancies
por: Sunakawa, Yu, et al.
Publicado: (2022)

Editorial: “The Role of Immune Checkpoint Molecules in Solid and Hematopoietic Stem Cell Transplantation”
por: Kordelas, Lambros, et al.
Publicado: (2021)

Cytomegalovirus infection among patients with cancer receiving immune checkpoint inhibitors
por: Panneerselvam, Kavea, et al.
Publicado: (2022)

Increased Intrahepatic Expression of Immune Checkpoint Molecules in Autoimmune Liver Disease
por: Macek Jilkova, Zuzana, et al.
Publicado: (2021)

Inhibiting the inhibitors: Checkpoints blockade in solid tumors
por: Mavilio, Domenico, et al.
Publicado: (2013)

The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors
por: Koustas, Evangelos, et al.
Publicado: (2020)

PD-1 Checkpoint Inhibitor Associated Autoimmune Encephalitis
por: Schneider, Stephanie, et al.
Publicado: (2017)

Neuritin, unmasked as a checkpoint for the pathogenesis of allergy and autoimmunity
por: Lucas, Michaela, et al.
Publicado: (2021)

Real world clinicopathologic observations of patients with metastatic solid tumors receiving immune checkpoint inhibitor therapy: Analysis from Kentucky Cancer Registry
por: Jacob, Aasems, et al.
Publicado: (2021)

Autoimmune Pancreatitis Exhibiting Multiple Mass Lesions
por: Shiokawa, Masahiro, et al.
Publicado: (2011)

Remarkable improvement of articular pain by biologics in a Multicentric carpotarsal osteolysis patient with a mutation of MAFB gene.
por: Nishikomori, R, et al.
Publicado: (2015)

Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy
por: Shiuan, Eileen, et al.
Publicado: (2017)

Follow-up Care for Patients Receiving Immune Checkpoint Inhibitors
por: Zhang, Liyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iv1hlopvkmpp61ndn68b5s17ho